1
|
Sarfaty M, Doroshenk M, Hotz J, et al:
Strategies for expanding colorectal cancer screening at community
health centers. CA Cancer J Clin. 63:221–231. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Zhang B, Zhang B, Chen X, Bae S, Singh K,
Washington MK and Datta PK: Loss of Smad4 in colorectal cancer
induces resistance to 5-fluorouracil through activating Akt
pathway. Br J Cancer. 110:946–957. 2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
He Z, Gao J, Wang Q, et al: S100P
contributes to chemosensitivity of human ovarian cancer cell line
OVCAR3. Oncol Rep. 20:325–332. 2008.PubMed/NCBI
|
4
|
Zhang N, Yin Y, Xu SJ and Chen WS:
5-Fluorouracil: mechanisms of resistance and reversal strategies.
Molecules. 13:1551–1569. 2008. View Article : Google Scholar : PubMed/NCBI
|
5
|
Phua LC, Mal M, Koh PK, Cheah PY, Chan EC
and Ho HK: Investigating the role of nucleoside transporters in the
resistance of colorectal cancer to 5-fluorouracil therapy. Cancer
Chemother Pharmacol. 71:817–823. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Manoochehri M, Karbasi A, Bandehpour M and
Kazemi B: Down-regulation of BAX gene during carcinogenesis and
acquisition of resistance to 5-FU in colorectal cancer. Pathol
Oncol Res. Oct 14–2013.(Epub ahead of print).
|
7
|
Anugraham M, Jacob F, Nixdorf S,
Everest-Dass AV, Heinzelmann-Schwarz V and Packer NH: Specific
glycosylation of membrane proteins in epithelial ovarian cancer
cell lines: glycan structures reflect gene expression and DNA
methylation status. Mol Cell Proteomics. May 22–2014.(Epub ahead of
print).
|
8
|
Lau KS and Dennis JW: N-Glycans in cancer
progression. Glycobiology. 18:750–760. 2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Zhang Z, Zhao Y, Jiang L, Miao X, Zhou H
and Jia L: Glycomic alterations are associated with multidrug
resistance in human leukemia. Int J Biochem Cell Biol.
44:1244–1253. 2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Beretta GL, Benedetti V, Cossa G, et al:
Increased levels and defective glycosylation of MRPs in ovarian
carcinoma cells resistant to oxaliplatin. Biochem Pharmacol.
79:1108–1117. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Ma H, Miao X, Ma Q, Zheng W, Zhou H and
Jia L: Functional roles of glycogene and N-glycan in multidrug
resistance of human breast cancer cells. IUBMB Life. 65:409–422.
2013. View
Article : Google Scholar : PubMed/NCBI
|
12
|
Hamaguchi J, Nakagawa H, Takahashi M, et
al: Swainsonine reduces 5-fluorouracil tolerance in the multistage
resistance of colorectal cancer cell lines. Mol Cancer. 6:582007.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Lee PL, Kohler JJ and Pfeffer SR:
Association of beta-1,3-N-acetylglucosaminyltransferase 1 and
beta-1,4-galactosyltransferase 1, trans-Golgi enzymes involved in
coupled poly-N-acetyllactosamine synthesis. Glycobiology.
19:655–664. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Srinivasan N, Bane SM, Ahire SD, Ingle AD
and Kalraiya RD: Poly N-acetyllactosamine substitutions on N- and
not O-oligosaccharides or Thomsen-Friedenreich antigen facilitate
lung specific metastasis of melanoma cells via galectin-3.
Glycoconj J. 26:445–456. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Narimatsu H: Human glycogene cloning:
focus on beta 3-glycosyltransferase and beta 4-glycosyltransferase
families. Curr Opin Struct Biol. 16:567–575. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ishida H, Togayachi A, Sakai T, et al: A
novel beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8), which
synthesizes poly-N-acetyllactosamine, is dramatically upregulated
in colon cancer. FEBS Lett. 579:71–78. 2005. View Article : Google Scholar : PubMed/NCBI
|
17
|
Hua D, Qin F, Shen L, et al: β3GnT8
regulates laryngeal carcinoma cell proliferation via targeting
MMPs/TIMPs and TGF-β1. Asian Pac J Cancer Prev. 13:2087–2093.
2012.
|
18
|
Jiang Z, Ge Y, Zhou J, Xu L and Wu SL:
Subcellular localization and tumor distribution of human
beta3-galactosyltransferase by beta3GalT7 antiserum. Hybridoma
(Larchmt). 29:141–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Shen K, Cui D, Sun L, Lu Y, Han M and Liu
J: Inhibition of IGF-IR increases chemosensitivity in human
colorectal cancer cells through MRP-2 promoter suppression. J Cell
Biochem. 113:2086–2097. 2012. View Article : Google Scholar : PubMed/NCBI
|
20
|
Seko A and Yamashita K: Activation of
beta1,3-N-acetylglucosaminyltransferase-2 (beta3Gn-T2) by
beta3Gn-T8. Possible involvement of beta3Gn-T8 in increasing
poly-N-acetyllactosamine chains in differentiated HL-60 cells. J
Biol Chem. 283:33094–33100. 2008. View Article : Google Scholar : PubMed/NCBI
|
21
|
Steet RA, Melancon P and Kuchta RD:
3′-Azidothymidine potently inhibits the biosynthesis of highly
branched N-linked oligosaccharides and poly-N-acetyllactosamine
chains in cells. J Biol Chem. 275:26812–26820. 2000.
|
22
|
Hung JS, Huang J, Lin YC, et al: C1GALT1
overexpression promotes the invasive behavior of colon cancer cells
through modifying O-glycosylation of FGFR2. Oncotarget.
5:2096–2106. 2014.PubMed/NCBI
|
23
|
Balog CI, Stavenhagen K, Fung WL, et al:
N-glycosylation of colorectal cancer tissues: a liquid
chromatography and mass spectrometry-based investigation. Mol Cell
Proteomics. 11:571–585. 2012. View Article : Google Scholar : PubMed/NCBI
|
24
|
Kudo T, Nakagawa H, Takahashi M, et al:
N-glycan alterations are associated with drug resistance in human
hepatocellular carcinoma. Mol Cancer. 6:322007. View Article : Google Scholar : PubMed/NCBI
|
25
|
Villacampa N, Almolda B, González B and
Castellano B: Tomato lectin histochemistry for microglial
visualization. Methods Mol Biol. 1041:261–279. 2013. View Article : Google Scholar : PubMed/NCBI
|
26
|
Elloway EA, Armstrong RA, Bird RA, Kelly
SL and Smith SN: Analysis of Acanthamoeba polyphaga surface
carbohydrate exposure by FITC-lectin binding and fluorescence
evaluation. J Appl Microbiol. 97:1319–1325. 2004.
|
27
|
Togayachi A, Kozono Y, Ishida H, et al:
Polylactosamine on glycoproteins influences basal levels of
lymphocyte and macrophage activation. Proc Natl Acad Sci USA.
104:15829–15834. 2007. View Article : Google Scholar : PubMed/NCBI
|
28
|
Mitsui Y, Yamada K, Hara S, Kinoshita M,
Hayakawa T and Kakehi K: Comparative studies on glycoproteins
expressing polylactosamine-type N-glycans in cancer cells. J Pharm
Biomed Anal. 70:718–726. 2012. View Article : Google Scholar : PubMed/NCBI
|
29
|
Kinoshita M, Mitsui Y, Kakoi N, Yamada K,
Hayakawa T and Kakehi K: Common glycoproteins expressing
polylactosamine-type glycans on matched patient primary and
metastatic melanoma cells show different glycan profiles. J
Proteome Res. 13:1021–1033. 2014. View Article : Google Scholar
|
30
|
Ni J, Jiang Z, Shen L, et al: β3GnT8
regulates the metastatic potential of colorectal carcinoma cells by
altering the glycosylation of CD147. Oncol Rep. 31:1795–1801.
2014.
|
31
|
Terada M, Khoo KH, Inoue R, et al:
Characterization of oligosaccharide ligands expressed on SW1116
cells recognized by mannan-binding protein. A highly fucosylated
polylactosamine type N-glycan. J Biol Chem. 280:10897–10913. 2005.
View Article : Google Scholar
|
32
|
Sirivolu VR, Vernekar SK, Ilina T,
Myshakina NS, Parniak MA and Wang Z: Clicking 3′-azidothymidine
into novel potent inhibitors of human immunodeficiency virus. J Med
Chem. 56:8765–8780. 2013.
|
33
|
Andreuccetti M, Allegrini G, Antonuzzo A,
et al: Azidothymidine in combination with 5-fluorouracil in human
colorectal cell lines: in vitro synergistic cytotoxicity and
DNA-induced strand-breaks. Eur J Cancer. 32A:1219–1226. 1996.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Meany DL and Chan DW: Aberrant
glycosylation associated with enzymes as cancer biomarkers. Clin
Proteomics. 8:72011. View Article : Google Scholar : PubMed/NCBI
|
35
|
Shiraishi N, Natsume A, Togayachi A, et
al: Identification and characterization of three novel
β1,3-N-acetylglucosaminyltransferases structurally related to the
β1,3-galactosyltransferase family. J Biol Chem. 276:3498–3507.
2001.
|
36
|
Huang C, Zhou J, Wu S, Shan Y, Teng S and
Yu L: Cloning and tissue distribution of the human B3GALT7 gene, a
member of the beta1,3-Glycosyltransferase family. Glycoconj J.
21:267–273. 2004. View Article : Google Scholar : PubMed/NCBI
|
37
|
Seko A and Yamashita K: Characterization
of a novel galactose beta1,3-N-acetylglucosaminyltransferase
(beta3Gn-T8): the complex formation of beta3Gn-T2 and beta3Gn-T8
enhances enzymatic activity. Glycobiology. 15:943–951. 2005.
View Article : Google Scholar : PubMed/NCBI
|